U32-17655-93512
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 640 / MO
- Registered
- 2021-10-17
- Relationship
- Child or adolescent in my care
- Guardian
- 5BV-17937-33272
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-05-06
Dose 2 — Pfizer-BioNTech
-
2021-10-17
Registered in v-safe
-
2021-11-06
Survey response — 6 months, dose 2, dependentMedDRA: Cough, Dyspnoea, Nasopharyngitis, Oropharyngeal pain, Pain, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Has had a cold 4 times since last injection. CONGESTION, COUGH, BODY ACHES, FEVER, SHORTNESS OF BREATH, SORE THROATMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | No |
| 2 | 2021-05-06 | Pfizer-BioNTech | No |
Free text
Release 10 — 6 months, dose 2, dependent
Symptoms: Has had a cold 4 times since last injection. CONGESTION, COUGH, BODY ACHES, FEVER, SHORTNESS OF BREATH, SORE THROAT
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release